Frost & Sullivan Industry experts host interactive briefing discussing innovating products boosting market growth
SANTA CLARA, California,Oct. 9, 2017 /PRNewswire/ -- Frost & Sullivan, the growth partnership company, announced today that it will host a live, complimentary Growth Innovation Leadership (GIL) briefing titled, "Microbiome: Revisiting the Micro and Macro"
In an era of convergence, the current growth trajectory across the microbiome industry englobes all verticals, from pharmaceutical and diagnostics to cosmetic and nutrition. Some of the milestones that have occurred in the microbiome field include the application of next-generation screening toward identifying and assessing microbial levels within the human gut. Using these microbial biomarkers, scientists are pushing the boundaries by identifying novel drug targets as well as probiotic or prebiotic products that could aid in balancing the microbial ecosystem within the human body.
"The Microbiome is coming of age. Microbial systems have largely been viewed as targets for disease prevention. Now that there is a recognition of the impact that microbial systems can have in promoting health, preventing a wide variety of disease and educating the immune system, the market is buzzing." Sudeep Basu
The webinar will provide expert insight on why investors think of the Microbiome as a hot portfolio segment and why there is such a rapid convergence of players in the field from across industry verticals. Come and surf this wave with Dr. Basu!
Key benefits of attending the briefing:
For more information and to register for the webinar, click here. The event will also be recorded and available for on-demand viewing at http://frost.ly/1ti.
About Frost & SullivanFrost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion
For more information, visit ww2.frost.com or call +1 (877) 463-7678.
Press Contact:Mariana FernandezFrost & Sullivan +1 (210) email@example.com
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All